Cisplatin (Cis-Diammineplatinum (II) dichloride/CIS) is one of the most potent chemotherapeutic agents widely used in treatment of various cancers. Naringenin (NAR), a natural lavonoid, protect against CIS-induced injury in rats without hampering CIS bene icial cytotoxic activity . Even though NAR exhibits therapeutic potency, clinical evolution of the molecule is embarrassed because of very less aqueous solubility which corresponds to low availability at the site of the tumor. In our former analysis, nanosuspension of naringenin (NARNS) was developed by the method of high-pressure homogenization. The study had been continued to evaluate the protective role of D-α-Tocopheryl polyethylene glycol succinate (TPGS) coated NARNS, against oxidative stressinduced hepato and nephrotoxicity in male Wistar rats upon CIS treatment. Induction of acute hepato and neprotoxicity was done by intraperitoneal injection (i.p) injection of CIS (7 mg/kg of body weight) and administration of NAR and NARNS. Administration of NARNS virtually suppressed CIS-induced and liver injury evidenced by a reduction of lipid peroxidation level, blood urea nitrogen, serum uric acid, creatinine and elevated enzymatic antioxidant activities of superoxide dismutase, catalase, and glutathione peroxidase in rats liver tissue. Histological studies substantiated the biochemical parameters. The study suggests that NARNS has strong hepato and nephroprotective effect compared to NAR.
INTRODUCTION
Even though CIS platin is an extensively used chemotherapeutic agent, it uses causes a wide range of side effects since they effect normal and cancerous tissues. Ototoxicity, neurotoxicity, nephrotoxicity, and hepatotoxicity are the major adverse events occurs due to the drug administration. CIS induced cytotoxicity is a contribution to reduce its application in therapy. Reactive oxygen species generation in cells caused by the CIS oxidative harm to mitochondria and inhibition of the antioxidant enzymes and arresting their activity leads to the release of free radicals. These mechanisms result in tissue damage and the toxic effect caused by CIS. Naringenin a lavanoid with its proved protec-tive mechanism in in lammation, antioxidant, neuroprotective, immunomodulator, anticarcinogenic agent, antiatherogenic and antiapoptotic activity were proved by the previous studies. Naringenin nanosuspension was formulated to overcome the bioavailability and solubility problems associated with the drug and studied further for their antiin lammatory activity. This formulation with a signi icantly high anti-in lammatory activity compared to naringenin was studied further in the current study to evaluate the hepatoprotective and nephroprotective activity against CIS platin induced toxicity (Yen et al., 2009; Sumathi et al., 2017) .
MATERIALS AND METHODS

Chemicals
TPGS was procured from commercial supplier Ludwigshafen, Germany. Cis was purchased from Sigma-Aldrich, Germany. NAR was bought from Zim laboratories Limited, Nagpur. Soya lecithin was obtained from Glenmark generics limited, Mumbai, India. And Chemicals purchased and used were of analytical grade.
Animals
Male albino Wistar rats weighing 130-140g were purchased for the study. Animals were exposed to controlled environmental conditions with constant temperature (25 ±2 • C) and humidity (55 ± 5%) and fed with laboratory feed and water. They were under a dark/light cycle of 14/10 h. Animals were in the speci ied laboratory conditions prior a week from the start of the study to ensure the animals were acclimatized to it. Institutional animal ethics committee (NCP/IAEC/2015-2016-04) was there for the performance of the study.
Hepatoprotective activity
30 Albino Wistar strain rats were equally distributed to ive groups, each containing six animals. Intraperitonial injection of (7 mg/kg b.w.) was administered to induce CIS-toxicity. Group I(Control group): Animals were considered as normal control throughout the study procedure. Group II was treated with a single dose of cisplatin i.p on the ifth day of the experiment at a dose of 7 mg/kg (Koyuncu et al., 2017) . Group III, rats of this group were administrated with silymarin (10 mg/kg i.p; once daily) for 9 days, and on 5th day CIS (7 mg/kg b w) was injected by i.p route (Singh et al., 2014) . Group IV (CIS-NAR) rats of this group were administered with NAR (50 mg/kg) for 9 days, and on the 5th day, CIS was injected by i.p at a dose of 7 mg/kg. Group V: (CIS-NARNS) rats of this group were administered with NARNS (50 mg/kgi. P; once daily) for 9 days and CIS at a dose of 7 mg/kg was injected by i.p.on the ifth day of the treatment (Kapoor and Kakkar, 2014) .
Animals were euthanized at the end of the experiment, under light anesthesia with diethyl ether; rats were euthanized by cervical decapitation. For biochemical assays, blood samples were collected, and serum was separated by centrifugation at 2500 rpm for 15 min. The samples were analyzed according to the prescribed procedure for required biochemical parameters. Total bilirubin and direct bilirubin was evaluated by Jendrassik & Grof's method (Garber, 1981) . Triglycerides activity of serum estimated using Glycrokinase peroxidase method. CHOD-PAP assay was preferred for the study of total cholesterol activity. Albumin and total protein were evaluated by the biuret method (Gornall et al., 1949) . AST, ALT and ALP levels were assessed from the collected serum with commercially available kits by using an autoanalyzer (Garba et al., 2011) . Livers were excised, rinsed, cleaned in saline and preserved in 10% formalin for histopathological study (Upreti et al., 1991) .
Nephroprotective activity
Albino Wistar strain rats were divided into ive groups of six each. Single-dose i.p. of CIS (7 mg/kg b.w.) was used to induce nephrotoxicity. Group I, the Control group animals, were selected as normal control. Group II-CIS treated group rats were administered with an intraperitoneal CIS i.p dose of 7 mg/kg on the ifth day from the start day of the experiment. Group III CIS-Cystone, rats of this group were administrated with Cystone (5ml/kg; p.o; once a day) for 9 days and on the 5th day CIS (7 mg/kg b w) was injected by i.p route (Rao and Rao, 1998; Sahoo et al., 2011) . Group IV-CIS-NAR, rats of this group, were administered with NAR (50 mg/kg i.p; once daily) for 9 days and on the 5th day, CIS was injected by i.p at a dose of 7 mg/kg. Group V-CIS-NARNS rats of this group were administered with NARNS (50 mg/kg i.p; once daily) for 9 days, and CIS at a dose of 7 mg/kg was injected by i.p. On the ifth day of the treatment (Rajappa et al., 2017) . Once the experiment was completed, rats were euthanized under light anesthesia with diethyl ether. Rats were euthanized by cervical decapitation. For biochemical assays, blood samples were collected and serum was separated by centrifugation at 2500 rpm for 15min and investigated for various biochemical constraints such as Blood Urea Nitrogen by DAM method (Allston, 1993) , Serum Creatinine by Jaffe's Alkaline picrate method (Vasiliades, 1976; Zaveri et al., 2011) , and serum uric acid were estimated using commercial kits (Hooper et al., 2000; Zare et al., 2006; Hooper et al., 1998) . Rats were euthanized, kidneys were excised, cleaned by rinsing with saline and10% formalin was used to preserve for histopathological study.
Tissue preparation
Dissected tissues were rinsed with cold PBS buffered solution (pH 7.4) and preserved at -80 0 C until the analysis. Tissue homogenate was prepared by homogenizing the tissue in a ratio of 1:3 (w/v; 1 g tissue with 3 ml PBS, pH 7.4) at 10000 rpm for 15min at 4 0 C. The Clear supernatant was used for the determine malondialdehyde (MDA) contents, reduced glutathione (GSH) and antioxidant enzyme activities.
Biochemical estimation of markers of oxidative stress in liver and kidneys
Estimation of lipid peroxidation levels
The process of lipid peroxidation is ixed in the supernatant collected after the homogenization of hepatic tissue by the thiobarbuturic acid (TBA) method that igures the MDA formation. 1ml of 1% TBA and 50µl of tissue homogenates were added with 500µl of 70% alcohol. The prepared samples in test tubes were subjected to boiling water for 20min. 50µl of acetone was added to all the samples once they were cooled and absorbance was determined at 535nm in a spectrophotometer (Niehaus and Samuelsson, 1968) .
Estimation of reduced glutathione levels
sulphydryl group-containing compound gives a yellow color with 5,5-dithiobis-2-nitrobenzoic acid. To 3ml of reaction mixture 50µl of tissue, the homogenate was added [1mg of β -NADPH + 1 mm glutathione reduced]. The sample was mixed by inversion and kept for equilibrated to 25 0 C. Samples were then analyzed spectrometrically 340 nm. The sample containing 50µl of phosphate buffer (pH 7) and dithiothreitol was taken as blank. 50µl of 0.042% of hydrogen peroxide was equally added to the samples and instantly mixed by downturn and measured the reduction in absorbance at 340nm for (Ellman, 1959) .
Estimation of antioxidant enzyme activities
The activity of Glutathione peroxidase (GPx) was calculated as an alteration of the calorimetric method (Flohé et al., 1984) , using hydrogen peroxide as a substrate in the existence of GSH. The absorbance was observed at 420nm. Glutathiones-transferase (GST) was determined by the ensuing the conjugation of glutathione with 1-chloro-2,4-dinitrobenzene (CDNB) at 340nm (Habig et al., 1974) . Superoxide dismutase (SOD) activity was determined based on the capacity of SOD to inhibit the autoxidation of pyrogallol (Saggu et al., 1989) . Catalase (CAT) activity was determined from the rate of decomposition of H 2 O 2 by the described method (Bergmeyer and Gawehn, 1974) .
Histopathological examination
Rats were sedated under light anesthesia with diethyl ether. The kidneys and liver of the animal were dissected out. The liver and kidney were further perfused with buffer saline to remove excess blood. Kidney was isolated and stored at −20 • C. The kidney was stabilized with 10% neutralized buffered formalin. Fixed materials were implanted in paraf in wax for the sectioning of the sample in a thickness of 5µm thickness. Slides were stained with hematoxylin and eosin for histological study.
Statistical analysis
The value represents as mean ± SEM. The results were studied using a one-way ANOVA followed by Dunnet test. * *p < 0.01, signi icant difference compared with the control group, * p < 0.05, signi icant difference compared with control group (n = 6).
RESULTS AND DISCUSSION
Parameters Assessed For Liver Functions
CIS administration resulted in signi icant elevation of bilirubin, triglycerides, total cholesterol, AST, ALT and ALP and bilirubin levels. Protein levels were signi icantly decreased in the test group compared to the normal control group indicating liver damage. Pretreatment with silymarin, NAR and NARNS remarkably prevented the biological changes induced by CIS. The effect of NAR and NARNS on liver parameters are given in Table 2 Table 1 .
Estimation of lipid peroxidation levels
Degenerative properties of free radicals are well indicated with the lipid peroxidation of biomembranes. Levels of MDA in the above groups were observed. MDA level was markedly better in the CIS treated animals compare to the control group. Silymarin, NAR and NARNS signi icantly cause reduction of CIS-elevated MDA level compared to those of the CIS group.
Effects of NARNS on GSH contents
GSH is a sul hydryl-having compound which is responsible for holding homeosis of cellular oxidation-reduction. Alterations in GSH may be re lected as a representation of functional cell damage. Levels of GSH in the above groups were noted. The toxicity of CIS appreciably reduced the levels of hepatic GSH in the CIS treated animals while comparison with the control group. Administration of silymarin, NAR and NARNS ameliorated the GSH levels in when compared with the CIS-treated group.
Figure 1: A) Effect of NAR & NARNS on antioxidant activity. B) Effect of NAR &NARNS on liver function
Effects of NARNS on antioxidant enzyme activities
The activities of GPx, GST, SOD and CAT of the studied liver tissue were shown in Table 2 , Figure 2 A & Figure 2 B. Administration of CIS lead to a lower GPx, GST, SOD and CAT activities while comparison with the control animals. But animals treated with silymarin expressed obviously increase in antioxidant enzyme level followed by NARNS as compared to CIS group.
Histopathological examination of liver tissue
The examination of liver tissues of the control group exhibited normal liver cell with a nucleus, central veins and preserved cytoplasm (Figure 3 A) . While the CIS treated rats where observed with liver sections where severe structural damage identi ied with necrosis around the central vein, degeneration and sinusoidal dilatation and in lammatory cell in iltration (Figure 3 B) . Histological section of the liver of the rat treated with CIS and silymarin (10 mg/kg) showed (Figure 3 C) marked development in contrast with CIS control group, and it reverted the histological appearance seen in the latter group to normal in examined tissue ields. However, the histopathological studies of liver sections from NAR (50mg/ kg) treated animals, were observed with a moderate degree of liver damage. Lesser in lammation, reduced hepatocyte degradation and centrilobular necrosis were observed with NAR treated group Figure 3 D) . The NARNS treated group was found with normal hepatocytes with least prominent in lammation. 
Parameters Assessed For Kidney Functions
Biochemical parameters such as blood urea nitrogen, Serum urea, uric acid and creatinine concentrations were signi icantly improved in the group treated with only CIS as matched with the normal control, on the other hand, groups treated with Cystone, NAR and NARNS showed signi icantly low values when equaled with the positive control group. NARNS was observed as predominant nephroprotective effect compared to NAR (* p < 0.05; * *p < 0.01) was represented in Table 3 and Figure 4 .
Histopathological examination of Kidney tissue
The sections of the kidney of normal control rats exhibited normal renal tubules and renal corpuscles. The glomeruli and Bowman's capsule appeared to be normal and prominent (Figure 5 A) . In the CIS control group, the kidney demonstrated discriminating tubular necrosis, dilated proximal convoluted tubules, plodding of epithelium due to desquamation and atrophic glomeruli, cellular debris in the tubular lumen and better tissue in the interstitium, were an indication of CIS-induced necrosis of kidney, which were signs of nephrotoxicity (Figure 5 B) . A Histological section of the kidney of the rat treated with CIS and Cystone (5 ml/kg) showed an improvement while comparing the CIS control group, and it reverted the histological characteristics observed in the latter group to normal in examining tissue ields. There were areas of tubular injury with tubular atrophy, tubular necrosis, and interstitial ibrosis, but these factors had a lesser intensity than in CIS control group (Figure 5 C) . Kidney histological sections of rats treated with CIS + NARNS (50 mg/kg) showed marked improvement, showing normal kidney histology and architecture, with interstitial ibrosis. There were some foci viewing tubular injury with, tubular atrophy, tubular necrosis and interstitial ibrosis, which were less intense than those seen in 
CONCLUSION
The study results clearly suggested that oxidative stress, in lammation and apoptosis/necrosis play a critical role in the pathogenesis of CIS induced hepato and nephrotoxicity. Pretreatment with NARNS signi icantly attenuated CIS-induced functional and histological liver and renal deterioration compared to NAR. One of the potential reason behind the NARNS-mediated protection of the cells were maybe the antioxidant activity. Before CIS administration, pretreatment with NARNS could inhibit the origin of free radicals produced by CIS prior to accomplish DNA and causing damage. The study delivers a solid proof for the use of the NARNS as hepato and nephroprotective activity against CIS induced damage in the liver and kidney. Therefore, NARNS may act as a chemoprotective agent to protect the cells from CIS-mediated toxicity.
